326 results on '"Fanale Daniele"'
Search Results
2. Scientific Communication and oncology – "The bridge between knowledge and patients"
3. Low plasma PD-L1 levels, early tumor onset and absence of peritoneal carcinomatosis improve prognosis of women with advanced high-grade serous ovarian cancer
4. Clinical relevance of exosome-derived microRNAs in Ovarian Cancer: Looking for new tumor biological fingerprints
5. Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors: Still looking through a dirty glass window?
6. R-Roscovitine (Seliciclib) prevents DNA damage-induced cyclin A1 upregulation and hinders non-homologous end-joining (NHEJ) DNA repair
7. Potential agnostic role of BRCA alterations in patients with several solid tumors: One for all, all for one?
8. MUTYH-associated tumor syndrome: The other face of MAP
9. BRCA1/2 variants of unknown significance in hereditary breast and ovarian cancer (HBOC) syndrome: Looking for the hidden meaning
10. Cancer of Exocrine Pancreas
11. Gastric Cancer: Locoregional Disease : General Section. Locoregional Disease
12. Tumor Board and Molecular Tumor Board
13. Nutrition and Cancer
14. Hereditary Cancers and Genetics
15. Biomarkers
16. Tumor Biology and Natural History
17. Can the tumor-agnostic evaluation of MSI/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors?
18. POLE, POLD1, and NTHL1: the last but not the least hereditary cancer-predisposing genes
19. Challenges and advances for the treatment of renal cancer patients with brain metastases: From immunological background to upcoming clinical evidence on immune-checkpoint inhibitors
20. Definition and management of colorectal polyposis not associated with APC/MUTYH germline pathogenic variants: AIFEG consensus statement
21. Role of the HIPPO pathway as potential key player in the cross talk between oncology and cardiology
22. BRCA-associated hereditary male cancers: can gender affect the prevalence and spectrum of germline pathogenic variants?
23. Effects of Dietary Restriction on Cancer Development and Progression
24. Circular RNA in Exosomes
25. Hereditary Cancers and Genetics
26. Cancer of Exocrine Pancreas
27. Nutrition and Cancer
28. Tumor Board and Molecular Tumor Board
29. Gastric Cancer: Locoregional Disease
30. Biomarkers
31. Tumor Biology and Natural History
32. Clinical relevance of exosome-derived microRNAs in Ovarian Cancer: looking for new tumor biological fingerprints
33. Cancer Clonal Evolution and Intra-tumor Heterogeneity
34. Liquid Biopsy in Gastrointestinal Stromal Tumor
35. Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC)
36. Involvement of Non-coding RNAs in Chemo- and Radioresistance of Colorectal Cancer
37. Non-coding RNAs Functioning in Colorectal Cancer Stem Cells
38. Oncogene Addiction in Solid Tumors
39. Targeted Therapies in Melanoma
40. The resistance related to targeted therapy in malignant pleural mesothelioma: Why has not the target been hit yet?
41. HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma
42. Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab: finding the missing links in the symbiotic immune-metabolic interplay
43. sj-docx-1-tam-10.1177_17588359231151845 – Supplemental material for Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab: finding the missing links in the symbiotic immune-metabolic interplay
44. Primary Epithelial Ovarian Neoplasms: New Concepts Concerning Origin, Pathogenesis and Classification Based on Morphology, Immunomarkers, Molecular Features, and Gene Expression Studies
45. Gene Signatures in CRC and Liver Metastasis
46. Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer?
47. Prognostic and Predictive Role of Tumor-Infiltrating Lymphocytes (TILs) in Ovarian Cancer
48. Effects of Dietary Restriction on Cancer Development and Progression
49. Immunometabolic predictive factors in Merkel cell carcinoma (MCC) patients treated with avelumab.
50. Impact of Different Selection Approaches for Identifying Lynch Syndrome-Related Colorectal Cancer Patients: Unity Is Strength
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.